Ex-BioNTech execs launch 'AI-native' cancer company
Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Newsletters and Deep Dive digital magazine
Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Novo Nordisk has joined forces with Amazon Web Services on a project that will lead to the creation of an AI co-innovation hub in London.
Four top AI figures at Google have left to form their own startup – Discovery Loop – dedicated to 'automating the experimental loop' in R&D.
Pathos AI has grown its oncology pipeline by licensing a bispecific ADC from Alphamab for $125m and partnering a breast cancer drug from AstraZeneca.
Healthcare organisations can’t afford to ignore agentic AI, but they also can’t afford to deploy it without the infrastructure to use it responsibly.
Editor's Picks
Newsletters and Deep Dive
digital magazine